SLC39A10 and neoplasm: The results showed that xenograft tumors formed by SLC39A10-overexpressing MKN45 cells grew faster and exhibited a significant increase in tumor weight in comparison with the tumors formed by control cells, while CX-4945 treatment effectively reversed the effect of SLC39A10 overexpression (Fig. 7a, b).